- Alcon: Developing Innovative Eye Care Treatments
Our mission is to provide innovative vision products that enhance quality of life by helping people see better From vision research to eye health, learn more at Alcon com
- About Us | Alcon
Alcon is the global leader in eye care, dedicated to helping people see brilliantly With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care
- Alcon México
Desde innovaciones quirúrgicas hasta productos para la visión, Alcon ayuda a las personas a ver de forma brillante Conozca nuestra empresa, oportunidades laborales, noticias para inversores y más
- Innovative Eye Care Products Solutions | Alcon
Alcon provides Eye Care Professionals comprehensive eye health education, hands-on experiential learning opportunities and cutting-edge virtual reality technology for immersive training experiences at our state-of-the-art facilities around the world
- Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone | Alcon
Alcon helps people see brilliantly As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives
- Alcon Careers
A career at Alcon means being part of a team dedicated to delivering sight-saving and sight-enhancing solutions throughout the world We aspire to lead the world in innovating life-changing vision products, because when people see brilliantly, they live brilliantly
- Alcon - Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic . . .
“Today marks a tremendous milestone for Alcon as TRYPTYR becomes our first prescription pharmaceutical treatment to be approved by the FDA since becoming an independent, publicly traded eye care company,” said David Endicott, CEO of Alcon
- Alcon Colombia
Desde innovaciones quirúrgicas hasta productos para la visión, Alcon ayuda a las personas a ver de forma brillante Conozca nuestra empresa, oportunidades laborales, noticias para inversores y más
|